Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ng, T. K. C.
Right arrow Articles by Cheng, A. F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, T. K. C.
Right arrow Articles by Cheng, A. F. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1996) 37, 465-472
© 1996 The British Society for Antimicrobial Chemotherapy


research-article

Rapid high performance liquid chromatographic assay for antifungal agents in human sera

T. K. C. Nga, R. C. Y. Chanb, F. A. B. Adeyemi-Dorob, S. W. Cheunga and A. F. B. Chengb,*

aDepartment of Microbiology, Prince of Wales Hospital Shatin New Territories, Hong Kong bDepartment of Microbiology, The Chinese University of Hong Kong Shatin New Territories, Hong Kong

Received 5 July 1995; accepted 26 September 1995


*Corresponding author

Serum concentration of seven antifungal agents, amphotericin B, 5-flucytosine, ketoconazole, fluconazole, itraconazole, miconazole and econazole were assayed using a single step sample preparation and an isocratic High Performance Liquid Chromatography (HPLC) procedure based on three mobile phases of similar components. Our method was simple, flexible and rapid, the assays being completed within half an hour. The method showed high reproducibility, good sensitivity with detection limits of 0.078 to 0.625 mg/L except for miconazole and econazole, and high recovery rates of 86–105%. Out of 24 therapeutic agents tested only aztreonam and trimethoprim were found to interfere with the assay of 5-flucytosine and fluconazole respectively, using this protocol. HPLC assay should be useful in the clinical laboratory for monitoring patients on antifungal therapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
M. L. Goodwin and R. H. Drew
Antifungal serum concentration monitoring: an update
J. Antimicrob. Chemother., January 1, 2008; 61(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. E. Lewis, G. Liao, J. Hou, G. Chamilos, R. A. Prince, and D. P. Kontoyiannis
Comparative Analysis of Amphotericin B Lipid Complex and Liposomal Amphotericin B Kinetics of Lung Accumulation and Fungal Clearance in a Murine Model of Acute Invasive Pulmonary Aspergillosis
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. P. Wiederhold, V. H. Tam, J. Chi, R. A. Prince, D. P. Kontoyiannis, and R. E. Lewis
Pharmacodynamic Activity of Amphotericin B Deoxycholate Is Associated with Peak Plasma Concentrations in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 469 - 473.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. E. Lewis, D. P. Kontoyiannis, R. O. Darouiche, I. I. Raad, and R. A. Prince
Antifungal Activity of Amphotericin B, Fluconazole, and Voriconazole in an In Vitro Model of Candida Catheter-Related Bloodstream Infection
Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3499 - 3505.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. E. Lewis, R. A. Prince, J. Chi, and D. P. Kontoyiannis
Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis
Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3208 - 3214.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. Barchiesi, A. M. Schimizzi, F. Caselli, A. Novelli, S. Fallani, D. Giannini, D. Arzeni, S. Di Cesare, L. F. Di Francesco, M. Fortuna, et al.
Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans
Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2435 - 2441.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
S. Machard, F. Theodoro, H. Benech, J.-M. Grognet, and E. Ezan
A Sensitive Amphotericin B Immunoassay for Pharmacokinetic and Distribution Studies
Antimicrob. Agents Chemother., March 1, 2000; 44(3): 546 - 550.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
R. E. Lewis, B. C. Lund, M. E. Klepser, E. J. Ernst, and M. A. Pfaller
Assessment of Antifungal Activities of Fluconazole and Amphotericin B Administered Alone and in Combination against Candida albicans by Using a Dynamic In Vitro Mycotic Infection Model
Antimicrob. Agents Chemother., June 1, 1998; 42(6): 1382 - 1386.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.